Listing: Blog
With significant pressure on pig production margins, maintaining positive respiratory health is fundamental for achieving healthy and efficient production. However, the impact of respiratory disease (lung…
NFU Scotland is calling on the UK government to urgently commission an independent review of food imports policy, warning that growing reliance on overseas production and…
Defra has been accused by MPs of ‘putting the cart before the horse’ in launching proposals to ban carbon dioxide (CO2) in abattoirs without clear scientific…
Listing: Timeline
Listing: Classic
Healthy lungs, Healthy Performance: Protecting pig performance with Cirbloc® M Hyo and Ceva Lung Program
0With significant pressure on pig production margins, maintaining positive respiratory health is fundamental for achieving healthy and efficient production. However, the impact of respiratory disease (lung health) is not always obvious. Reduced average daily gain (ADG) and poorer feed efficiency can quietly increase production costs, even in the absence of obvious clinical signs. Mycoplasma hyopneumoniae (M. hyo) and Porcine Circovirus Type 2 (PCV2) are two important contributors to these production losses, thereby making effective and measurable control essential. Introducing Cirbloc® M Hyo Cirbloc® M Hyo is a ready-to-use combination vaccine containing a PCV2d antigen and Ceva’s hyopneumoniae strain 2940, the…